World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
47330
World Ranking
15348
National Ranking
1410

Overview

Stuart M. Cobbe is affiliated with the University of Glasgow in the United Kingdom. Their research primarily spans the field of Medicine, with a focus on several subfields including Surgery, Endocrinology, Diabetes and Metabolism, Emergency Medicine, and Economics and Econometrics.

Their work addresses key topics related to Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, HIV-related health complications and treatments, as well as Health Systems, Economic Evaluations, and Quality of Life.

The scientist has contributed to multiple peer-reviewed publications, with frequent appearances in prominent journals such as The Lancet and The Lancet Diabetes & Endocrinology. Two notable recent papers include:

  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022, The Lancet)
  • Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis (2024, The Lancet Diabetes & Endocrinology)

Throughout their career, Stuart M. Cobbe has collaborated closely with other researchers. Frequent co-authors include:

  • Christina Reith
  • Colin Baigent
  • Lisa Blackwell
  • Jonathan Emberson
  • Enti Spata

The scientist's research contributions demonstrate intersections between clinical medicine and epidemiology, particularly around cardiovascular and metabolic diseases. By integrating data from randomized controlled trials, their work supports a deeper understanding of the effects of statin therapy on health outcomes.

Best Publications

  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

    J Shepherd;S M Cobbe;I Ford;C G Isles

  • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

    James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen

  • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

    Bengt C. Fellström;Alan G. Jardine;Roland E. Schmieder;Hallvard Holdaas

  • Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

    Naveed Sattar;Allan Gaw;Olga Scherbakova;Ian Ford

  • West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials

    J Shepherd;SM Cobbe;AR Lorimer;JH McKillop

  • The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

    Jill Belch;Angus MacCuish;Iain Campbell;Stuart Cobbe

  • Pravastatin and the Development of Diabetes Mellitus Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

    Dilys J. Freeman;John Norrie;Naveed Sattar;R. Dermot G. Neely

  • Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation

    Robby Nieuwlaat;Alessandro Capucci;A John Camm;S Bertil Olsson

  • Recommended Guidelines for Reviewing, Reporting, and Conducting Research on In-Hospital Resuscitation: The In-Hospital ‘Utstein Style’

    Richard O. Cummins;Douglas Chamberlain;Mary Fran Hazinski;Vinay Nadkarni

  • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

    CJ Packard;J Shepherd;SM Cobbe;Jane B Ford

  • Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors The Prospective Pravastatin Pooling Project

    Frank M. Sacks;Andrew M. Tonkin;James Shepherd;Eugene Braunwald

  • Smoke-free legislation and hospitalizations for acute coronary syndrome

    Jill Pell;Sally Haw;Stuart M Cobbe;David E Newby

  • Long-Term Follow-up of the West of Scotland Coronary Prevention Study

    Ian Ford;Heather Murray;Chris J Packard;James Shepherd

  • Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease

    Marcello Tonelli;Chris Isles;Gary C Curhan;Andrew Maxwell Tonkin

  • Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

    Naveed Sattar;Olga Scherbakova;Ian Ford;Denis St. J. O’Reilly

  • Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.

    Nikolaos Dagres;Robby Nieuwlaat;Panos E. Vardas;Dietrich Andresen

  • The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

    James Shepherd;Gerard Jan Blauw;Michael B Murphy;Stuart M Cobbe

  • Reduction of Stroke Events With Pravastatin The Prospective Pravastatin Pooling (PPP) Project

    Robert P. Byington;Barry R. Davis;Jonathan F. Plehn;Harvey D. White

  • asymptomatic peripheral arterial disease and antioxidants in patients with diabetes and randomised placebo controlled trial of aspirin factorial disease and diabetes (POPADAD) trial: The prevention of progression of arterial

    Stuart Pringle;Ron MacWalter;John McKnight;Colin Semple

  • Task Force on Sudden Cardiac Death of the European Society of Cardiology: erratum

    S.G. Priori;E. Aliot;C. Blomstrom-Lundqvist;L. Bossaert

Frequent Co-Authors

Ian Ford
Ian Ford University of Glasgow
Peter W. Macfarlane
Peter W. Macfarlane University of Glasgow
Chris J. Packard
Chris J. Packard Glasgow Royal Infirmary
Naveed Sattar
Naveed Sattar University of Glasgow
Jill P. Pell
Jill P. Pell University of Glasgow
Godfrey L. Smith
Godfrey L. Smith University of Glasgow
James Shepherd
James Shepherd University of Glasgow
David J. Stott
David J. Stott University of Glasgow
Mark C. Petrie
Mark C. Petrie University of Glasgow
Keith G. Oldroyd
Keith G. Oldroyd Golden Jubilee National Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens up a wide range of alternative and supplementary pathways through online education. Those interested in the business side of healthcare can explore a health administration degree, which prepares graduates for leadership roles in hospitals, clinics, and other medical organizations.

For registered nurses seeking advanced roles, structured bridge programs like asn to np help transition from associate-level nursing credentials directly into nurse practitioner and other specialized positions, boosting career prospects.

Nutrition is also a critical part of health professions. Earning a nutrition bachelor degree online enables students to focus on dietetics, health coaching, or wellness, while maintaining flexibility for working professionals.

If you’re aiming for a high-level executive position in healthcare, consider accredited options like the best online mha programs to develop critical management and policy skills. Exploring these related online degrees can unlock diverse opportunities across the healthcare sector.

Best Scientists Citing Stuart M. Cobbe

Trending Scientists

Recently Published Articles